We are live on ! Find out more
ALBO

Albireo Pharma Inc
ALBO

Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

50 hedge funds and large institutions have $213M invested in Albireo Pharma Inc in 2018 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 15 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 5

161% more capital invested

Capital invested by funds: $81.8M → $213M (+$131M)

150% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 6

67% more funds holding

Funds holding: 30 → 50 (+20)

Holders
50
Holders Change
+20
Holders Change %
+66.67%
% of All Funds
1.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
15
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$21.1M
2
ACH
ArrowMark Colorado Holdings
Colorado
+$13.6M
3
PA
Perceptive Advisors
New York
+$12.9M
4
Federated Hermes
Federated Hermes
Pennsylvania
+$10.4M
5
AG
Artal Group
Luxembourg
+$8.35M

Top Sellers

Rank Fund Capital Flow
1
SAM
Sectoral Asset Management
Quebec, Canada
-$2.36M
2
Renaissance Technologies
Renaissance Technologies
New York
-$953K
3
SFM
Sphera Funds Management
Israel
-$907K
4
CIBC Private Wealth Group
CIBC Private Wealth Group
Georgia
-$51K
5
Morgan Stanley
Morgan Stanley
New York
-$29.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
$55.5M +$12.9M +384,330 +29%
TGHSA
2
TPG Group Holdings (SBS) Advisors
Texas
$25.3M – – –
Fidelity Investments
3
Fidelity Investments
Massachusetts
$20.4M +$21.1M +627,732 New
AG
4
Artal Group
Luxembourg
$17.8M +$8.35M +247,841 +83%
ACH
5
ArrowMark Colorado Holdings
Colorado
$13.2M +$13.6M +405,352 New
Federated Hermes
6
Federated Hermes
Pennsylvania
$10.1M +$10.4M +309,925 New
BBA
7
Baker Bros. Advisors
New York
$8.14M +$1.68M +50,000 +25%
BI
8
BVF Inc
California
$7.33M +$7.58M +225,000 New
AWG
9
Alpha Wave Global
New York
$5.7M +$5.89M +175,000 New
SAM
10
Sectoral Asset Management
Quebec, Canada
$5.63M -$2.36M -70,000 -29%
Millennium Management
11
Millennium Management
New York
$5.07M +$3.67M +109,017 +234%
TCM
12
Tekla Capital Management
Massachusetts
$4.07M +$4.21M +125,000 New
DM
13
Deerfield Management
New York
$3.91M +$4.04M +120,000 New
Vanguard Group
14
Vanguard Group
Pennsylvania
$3.04M +$2.1M +62,262 +201%
Renaissance Technologies
15
Renaissance Technologies
New York
$3.01M -$953K -28,300 -23%
HA
16
Heartland Advisors
Wisconsin
$2.97M +$3.07M +91,323 New
CC
17
Chicago Capital
Illinois
$2.96M +$3.06M +90,831 New
BlackRock
18
BlackRock
New York
$2.5M +$2.17M +64,444 +522%
DZ Bank
19
DZ Bank
Germany
$2.04M +$2.11M +62,647 New
Victory Capital Management
20
Victory Capital Management
Texas
$1.87M +$1.93M +57,380 New
Goldman Sachs
21
Goldman Sachs
New York
$1.7M +$1.75M +52,107 New
Geode Capital Management
22
Geode Capital Management
Massachusetts
$1.55M +$535K +15,884 +50%
WMSA
23
Weiss Multi-Strategy Advisers
New York
$1.14M +$1.18M +35,000 New
Susquehanna International Group
24
Susquehanna International Group
Pennsylvania
$1.02M +$1.06M +31,415 New
BC
25
Birchview Capital
Vermont
$782K +$808K +24,000 New
1
2 3

ALBO Hedge Fund Activity: Q1 2018 in Review

50 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q1 2018, worth a combined $213M — up 161% from $81.8M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new ALBO positions and 5 closed out — a net gain of 20 holders — while 15 added to existing stakes and 6 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $21.1M. The largest seller was Sectoral Asset Management, cutting an estimated $2.36M.

  • 50 institutional investors held Albireo Pharma Inc (ALBO) as of Q1 2018, up from 30 in Q4 2017.
  • Funds reported $213M of Albireo Pharma Inc stock for Q1 2018, up 161% quarter-over-quarter.
  • 25 funds opened new Albireo Pharma Inc positions in Q1 2018 and 5 closed out, a net change of +20 holders.
  • The largest Albireo Pharma Inc buyer in Q1 2018 was Fidelity Investments, an estimated $21.1M added.
  • The largest Albireo Pharma Inc seller in Q1 2018 was Sectoral Asset Management, an estimated $2.36M sold.

Based on aggregated 13F filings for Q1 2018.